brazil's ip pharma policy and the expectation for the 2014 elections webinar aug 27

© Simões IP - all rights reserved© Simões IP - all rights reserved

imõesimõesimõesimões Intellectual PropertyIntellectual PropertyIntellectual PropertyIntellectual Property

BrazilBrazilBrazilBrazilBrazil's IP Pharma policy and the expectation for the 2014 Brazil's IP Pharma policy and the expectation for the 2014 Brazil's IP Pharma policy and the expectation for the 2014 Brazil's IP Pharma policy and the expectation for the 2014 electionselectionselectionselections

Igor SimõesIgor SimõesIgor SimõesIgor Simões

© Simões IP - all rights reserved


� EXPERT SPEAKER(S)

Igor SimõesManaging Partner / Patent AttorneySimões Intellectual Property


� Introduction

� Recent developments on IP policy in Brazil

� The challenges of pharma industry

� The backlog of non-examined cases at the PTO

� Update on hot topics: ANVISA and Mailbox Patents

� Presidential elections: What can we expect from main

candidates?

AgendaAgendaAgendaAgenda


� Research & Development investments in Brazil.

� The Innovation Law n. 10,973/2004 and the Good Law n. 11,196/2005

� The Productive Development Policy (PDP)and its goals.

� The BPTO’s restructuring

� Recent developments on IP policy in BrazilRecent developments on IP policy in BrazilRecent developments on IP policy in BrazilRecent developments on IP policy in Brazil


� Brazil as an emerging economy: patents granted and patents received.

� Could the situation change?

� The necessary changes in the patent system.


� The battle between the BPTO and ANVISA and how it affects the

country’s economy

� The importance of an FTO report on the launch of a product on the

market.

� The challenges of The challenges of The challenges of The challenges of pharmapharmapharmapharma industryindustryindustryindustry


� The Brazilian PTO’s reasons for taking so long on an application analysis.

� How does it affect the country’s development?

� Ways of solving this issue.

� The backlog of nonThe backlog of nonThe backlog of nonThe backlog of non----examined cases at the PTOexamined cases at the PTOexamined cases at the PTOexamined cases at the PTO


� The “mailbox” patents: What are they?

� The BPTO’s request and the decisions on it.

� Update on hot topics: ANVISA and Mailbox PatentsUpdate on hot topics: ANVISA and Mailbox PatentsUpdate on hot topics: ANVISA and Mailbox PatentsUpdate on hot topics: ANVISA and Mailbox Patents

� Presidential elections: What can we expect from main candidates?Presidential elections: What can we expect from main candidates?Presidential elections: What can we expect from main candidates?Presidential elections: What can we expect from main candidates?


THANK YOU!